Infiltration of inflammatory cells into pancreatic islets of Langerhans and selective destruction of insulin-secreting ␤-cells are characteristics of type 1 diabetes. Uncoupling protein 2 (UCP2) is a mitochondrial protein expressed in immune cells. UCP2 controls macrophage activation by modulating the production of mitochondrial reactive oxygen species (ROS) and MAPK signaling. We investigated the role of UCP2 on immune cell activity in type 1 diabetes in Ucp2-deficient mice. Using the model of multiple low-dose streptozotocin (STZ)-induced diabetes, we found that autoimmune diabetes was strongly accelerated in Ucp2-KO mice, compared with Ucp2-WT mice with increased intraislet lymphocytic infiltration. Macrophages from STZ-treated Ucp2-KO mice had increased IL-1␤ and nitric oxide (NO) production, compared with WT macrophages. Moreover, more macrophages were recruited in islets of STZ-treated Ucp2-KO mice, compared with Ucp2-WT mice. This finding also was accompanied by increased NO/ROS-induced damage. Altogether, our data show that inflammation is stronger in Ucp2-KO mice and islets, leading to the exacerbated disease in these mice. Our results highlight the mitochondrial protein UCP2 as a new player in autoimmune diabetes.
M
itochondria are important organelles for cellular functions, including ATP synthesis. Oxidative glucose metabolism in pancreatic ␤-cells increases the ATP/ADP ratio, leading to insulin release. Uncoupling protein 2 (UCP2) is a mitochondrial carrier protein expressed in pancreatic ␤-cells (1, 2) and immune cells (3, 4) .
In pancreatic ␤-cells, UCP2 was reported to alter the yield of ATP synthesis from glucose, and it has been proposed as a negative regulator of glucose-stimulated insulin secretion (2) . In other respects, there is much evidence for the influence of UCP2 on immune responses. First, Ucp2-KO mice exhibit increased resistance to a Toxoplasma gondii or Listeria monocytogenes infection (4, 5) . Second, in an LDL receptor-null background, Ucp2-KO mice develop greater and more unstable atherosclerotic plaques than WT mice (6) . Third, in experimental autoimmune encephalomyelitis, a murine model of multiple sclerosis, Ucp2-KO mice develop higher disease scores than Ucp2-WT mice (7) . We showed that UCP2 regulates LPS-induced reactive oxygen species (ROS) signaling in macrophages (8) . MAPK activation in Ucp2-KO macrophages is quicker and stronger than in WT macrophages (8) , leading to increased nitric oxide (NO), cytokine production, and migration ability (8, 9) . Consistent with these findings, overexpression of UCP2 in macrophages is associated with diminished NO production (10) and decreased migration capacity (11) .
Given the evidence for a role of UCP2 in the immune system, in macrophages, and in ␤-cell function, we investigated whether UCP2 affects the development of autoimmune diabetes by using the model of multiple low-dose of streptozotocin (STZ). In this report, we show that the absence of UCP2 renders animals more sensitive to the onset of diabetes in mice. Although UCP2 is implicated in type 2 diabetes (1, 2), our present results highlight the mitochondrial UCP2 as a new player in the field of autoimmune diabetes.
Results

Ucp2-KO Mice Are More Sensitive to Multiple Low Doses of STZ (MLDS)
. UCP2 function in ␤-cells and immune responses led us to investigate the role of UCP2 in the development of autoimmune diabetes by injecting Ucp2-WT and Ucp2-KO mice with MLDS, which is an immune-mediated murine diabetes model in which hyperglycemia and diabetes are achieved after five daily injections of subdiabetogenic doses of STZ (12) , leading to insulitis and selective ␤-cell loss. The development of diabetes, defined as a blood glucose concentration of Ͼ200 mg/dl on at least two consecutive measurements, was monitored as described in Methods (13) . Our results revealed a striking difference between the genotypes. The average time of appearance of hyperglycemia was 43 days in Ucp2-WT mice, whereas it took only 26 days in Ucp2-KO mice (P Ͻ 0.05) (Fig. 1) . The severity of hyperglycemia was stronger in Ucp2-KO mice (Table 1) .
Lack of UCP2 in ␤-Cells Does Not Affect MLDS-Induced Diabetes.
Because UCP2 is expressed in ␤-cells and immune cells, the accelerated MLDS-induced diabetes in Ucp2-KO mice could result from an effect of UCP2 on ␤-cell survival against an inflammatory insult or immune cell activation. To distinguish between these two possibilities, we first investigated whether UCP2 deficiency in islets may affect cytokine-induced ␤-cell death, the major death signal for ␤-cells (14, 15) . A mechanism by which cytokines impair ␤-cell function and, in part, mediate ␤-cell death is by induction of the expression of the inducible form of NO synthase (iNOS) and thus NO production (16) (17) (18) . We measured NO production of islets isolated from Ucp2-WT and Ucp2-KO mice treated or not with IL-1␤ and IFN-␥ for 48 h, as previously described (19) . NO production was similar in islets of both genotypes ( Fig. 2A) , and no difference was observed from the analysis of cell viability after 72 h (Fig. 2B) .
To directly address the possibility that Ucp2-KO ␤-cells are more sensitive to STZ, a single high-dose injection of STZ was administered to Ucp2-WT and Ucp2-KO mice. Under these conditions, the development of diabetes was similar in both groups of mice (n ϭ 6) (data not shown). The similar sensitivity to a single high-dose injection suggests that the absence of UCP2 in ␤-cells does not seem to affect ␤-cell sensitivity to STZ per se, although a difference at submaximal doses of STZ cannot be excluded.
Similar ␤-cell sensitivity to STZ and similar cytokine-induced NO production and cell death strongly suggest that the absence of UCP2 expression in ␤-cells is not responsible for the greater susceptibility of Ucp2-KO mice to MLDS-induced diabetes.
Increased NO and Cytokine Production of Macrophages from MLDS-
Treated Ucp2-KO Mice. Earlier studies have shown that Ucp2-KO macrophages have increased MAPK activation in response to LPS and therefore produce more NO (8) . NO and IL-1␤ are two important mediators in inflammation and ␤-cell death (20, 21) . To investigate whether MLDS treatment differentially affected macrophage activity in Ucp2-KO and Ucp2-WT mice, peritoneal macrophages were isolated from both types of mice. On day 10, when neither Ucp2-KO nor Ucp2-WT mice were hyperglycemic, NO production was enhanced in macrophages isolated from MLDS-treated Ucp2-KO mice, compared with Ucp2-WT mice upon stimulation in vitro with LPS (P Ͻ 0.01) (Fig. 3A) . IL-1␤ production also was higher in Ucp2-KO macrophages (P Ͻ 0.05) (Fig. 3B ). The productions of NO and IL-1␤ were increased, compared with macrophages from untreated mice, suggesting that macrophages from MLDS mice on day 10 were in a primed state potentiating their activation ( Fig. 3 A and B) . These results argue in favor of an early influence of UCP2 on immune response and on macrophage activity in the MLDS model.
Increased IL-1␤ Concentration in MLDS-Treated Ucp2-KO Mice.
MLDS is an immune-mediated diabetes. Cytokines and chemokines are known mediators of immune responses that are able to recruit and activate leukocytes. We measured the levels of cytokines in the serum and whole pancreas of MLDS-treated mice on days 10 and 19. IL-1␤ levels in the serum and pancreas were 3-to 5-fold higher in Ucp2-KO mice at day 10 (P Ͻ 0.05) (Fig. 4A ). This difference also was observed on day 19 in serum (P Ͻ 0.05) (Fig.  4B ). At the same time, concentrations of IL-6 and MCP-1 were not different between Ucp2-KO and Ucp2-WT mice, whereas 
Fig. 2.
Similar response of Ucp2-WT and Ucp2-KO islets to cytokines.(A) NO levels in medium of islets exposed in vitro to IL-1␤ (50 units/ml and IFN-␥ (1,000 units/ml) for 48 h. (B) WST assay was used to measure the viability of islets exposed to IL-1␤ (50 units/ml) and IFN-␥ (1,000 units/ml) for 72 h. Data pooled from four separate experiments are presented as the mean Ϯ SEM (total number of Ucp2-WT mice, n ϭ 8; Ucp2-KO mice, n ϭ 9). ** , P Ͻ 0.01; *** , P Ͻ 0.001. higher levels of IL-6 and MCP-1 were reported in Ucp2-KO mice in response to L. monocytogenes (4) . We show here that MLDStreated Ucp2-KO mice exhibit an increased inflammatory state, which is in line with the higher activity of macrophages from MLDS-treated Ucp2-KO mice. This finding supports the conclusion that the accelerated diabetes in Ucp2-KO mice results from higher immune cell activity.
Increased Lymphocytic Intraislet Infiltration in MLDS-Treated Ucp2-KO
Mice. To determine whether the higher inflammatory state in Ucp2-KO mice was associated with increased insulitis, the degree of insulitis of pancreata from MLDS-treated mice was analyzed by using the following scores: 0, no infiltration; 1, minor infiltration; 2, clear infiltration. Although neither Ucp2-KO nor Ucp2-WT mice were hyperglycemic on day 10, the degree of infiltration was already significantly higher in Ucp2-KO mice (P Ͻ 0.001) (Fig. 5A ). On day 19, when hyperglycemia was clearly manifest in Ucp2-KO mice, but still not in Ucp2-WT mice, the difference was even more accentuated (P Ͻ 0.001) (Fig. 5B) . These results underline the contribution of UCP2 in the immune response in MLDS-induced diabetes.
Early Increased Macrophagic Infiltration and NO/ROS-Induced Dam-
age in Islets of MLDS-Treated Ucp2-KO Mice. Macrophages are crucial players in the pathogenesis of type 1 diabetes, being the first cells to accumulate into islets (22) (23) (24) . Given that Ucp2-KO macrophages exhibited increased migration ability (8) and NO production ( Fig. 3 ) (8, 9), we wondered whether there were any early macrophage-selective differences between Ucp2-KO and Ucp2-WT islets. This idea was investigated on islets presenting the same minor lymphocytic infiltration score (Fig. 6 ) on day 10, when neither Ucp2-KO nor Ucp2-WT mice were hyperglycemic. The number of macrophages in Ucp2-KO islets was clearly higher than in Ucp2-WT islets (29.4 Ϯ 2.2 macrophages/islets/ mice vs. 13 Ϯ 2.2, respectively; P Ͻ 0.01) (Fig. 6 B and E) . In addition, measurements of nitrotyrosine staining, a marker of NO/ROS-induced damage, was strongly positive throughout Ucp2-KO islets, whereas in Ucp2-WT islets it was barely detectable and only in the periphery (49.2 Ϯ 4.8 nitrotyrosinepositive cells/islets/mouse vs. 20 Ϯ 1.7, respectively; P Ͻ 0.001) (Fig. 6 C and F) . These results indicate that macrophagic infiltration and damage to islets is higher in Ucp2-KO mice, which is in agreement with the accelerated occurrence of diabetes in Ucp2-KO mice and the higher IL-1␤ and NO productions. Moreover, these data illustrate the liveliness and activity of Ucp2-KO macrophages in MLDS-induced diabetes.
Discussion
Because mitochondria couple glucose metabolism to insulin secretion, defects in mitochondrial functions are often associated with type 2 diabetes (25). In type 1 diabetes, the role of mitochondria has mainly been of interest in cytokine-induced ␤-cell apoptosis (26, 27) . Whereas the role of UCP2 in type 2 diabetes and autoimmunity is well investigated (1, 2, 6, 7), our manuscript reports the importance of a mitochondrial protein, UCP2, in autoimmune diabetes by using the MLDS murine model for immune-mediated diabetes (12) . Our results show that the appearance of diabetes was clearly accelerated in Ucp2-KO mice, compared with Ucp2-WT mice. This phenomenon was attributed, in part, to an enhanced macrophage-mediated immune response. In autoimmune diabetes, the infiltration of macrophages into islets precedes and is a prerequisite for lymphocytic insulitis and ␤-cell destruction (23, 24, 28) . Macrophages mediate islet damage through ROS, NO, and cytokine production. Therefore, suppression of macrophages or inhibition of their activity was shown to slow insulitis progression in NOD mice (29) or prevent MLDS-induced diabetes (22, 30, 31) . We recently reported that increased mitochondrial ROS production in Ucp2-KO macrophages allows quicker and stronger p38 and ERK signaling, leading to increased cell activity (8) . Here we observed a higher number of macrophages in islets of MLDS-treated Ucp2-KO mice, probably resulting from the increased migration ability of Ucp2-KO macrophages (8) , as previously reported in atherosclerotic plaques (6) and in the spleen after infection with L. monocytogenes (4) . In addition, we showed that macrophages isolated from MLDS-treated Ucp2-KO mice exhibited increased NO and IL-1␤ productions. This finding was associated with higher levels of IL-1␤ in the serum and pancreas of MLDS-treated Ucp2-KO mice, as well as stronger NO/ROS-induced damage in islets of MLDStreated Ucp2-KO mice, compared with WT mice. These results are important given the role of IL-1␤ and NO in ␤-cell death and type 1 diabetes (15, 20, 32) . For instance, IL-1␤ receptor deficiency slows the development of diabetes in NOD mice (33) , whereas use of an IL-1␤ trap suppressed toxic effects of cytokine-mediated cytotoxicity (34) . In addition, transgenic mice overexpressing iNOS specifically in ␤-cells develop spontaneous insulin-dependent diabetes (35) , whereas iNOS-KO mice are resistant to MLDS-induced diabetes (36) .
Higher insulitis scores in Ucp2-KO mice result from either the role of UCP2 in lymphocyte activation (7) or the increased local activity of Ucp2-KO macrophages, favoring the recruitment of immune cells. Increased NO production, IL-1␤ concentrations, and immune cell recruitment into islets of Ucp2-KO mice are responsible for stronger inflammation in these animals. Therefore, islets of MLDS-treated Ucp2-KO mice are in a more deleterious environment in vivo than islets of Ucp2-WT mice, contributing to the exacerbated disease (Fig. 7) . Our data are consistent with previous observations of heightened inflammatory responses in Ucp2-KO mice (4) (5) (6) (7) 9) .
Because UCP2 seems to control the mitochondrial ROS production, UCP2 was shown to promote or inhibit cell death depending on the cell type and stimulus (8, 37, 38) . However, classically performed cytokine-induced NO production and cell death experiments showed no difference between Ucp2-KO and Ucp2-WT islets in vitro. Actually, expression of superoxide dismutase and/or catalase, two enzymes of the antioxidant system, in ␤-cells neither provides protection against cytokineinduced toxicity (39) nor changes the incidence of diabetes in NOD mice (40) . In this regard, ␤-cell death should not be affected by a UCP2 deficiency in autoimmune diabetes. However, this notion cannot be ruled out entirely because our experiments were performed in vitro on whole islets. Thus, cytokines may not have maximally reached the ␤-cell core because of the tight junctions compartmentalizing the interstitium.
The importance of NO, IL-1␤, and macrophages is far from being restricted to type 1 diabetes. Macrophages are a main source of proinflammatory cytokines and NO. Experiments with mice deficient in IL-1or IL-1 receptor antagonist, as well as the inhibition of NO synthesis, have demonstrated their role in inflammatory or autoimmune diseases such as lupus or rheumatoid arthritis (41, 42) , and further studies on UCP2 in these pathologies would be instructive. Indeed, in humans, high levels of UCP2 were associated with reduced susceptibility to multiple sclerosis (43) and reduced risk of diabetic neuropathy in type 1 diabetes (44) .
Because UCP2 down-regulation in macrophages upon stimulation enhances p38 and ERK activation (8) and these MAPK are up-regulated in Ucp2-KO macrophages, it is interesting to note that both p38 and ERK phosphorylation is increased in type 1 diabetes monocytes (45) . Therefore, the development of strategies to induce UCP2 or inhibit its down-regulation in immune cells would be promising in autoimmunity. First, data are encouraging because in vitro UCP2 overexpression in macrophages diminished their migration capacity and NO production (10, 11) . More important, UCP2 overexpression in mice decreases their responsiveness to LPS in terms of cytokine (46) and provides protection in acute brain injury (37) . Future studies in the context of autoimmunity are now expected.
So far, UCP2 is recognized as a negative regulator of insulin secretion in ␤-cells, implicating UCP2 only in type 2 diabetes (1, 2). Our present results highlight the importance of mitochondrial functions in the framework of type 1 diabetes and, more generally, in inflammatory or autoimmune diseases.
Methods
Animals. Studies on mice were performed in agreement with the institutional Centre National de la Recherche Scientifique guidelines defined by the European Community guiding principles and by the French decree no. 87/848 of October 19, 1987 . Authorization to perform animal experiments was given by the French Minister of Agriculture, Fisheries, and Food (A92580 issued February 2, 1994; A92148 issued May 14, 2002 ). Ucp2-WT and Ucp2-KO littermate mice raised in a C57BL/6J genetic background for 10 generations were maintained under a 12-h light/12-h dark schedule with food and water ad libitum.
Isolation and Culture of Pancreatic Islets. Mice were killed, and islets of Langerhans were isolated after collagenase digestion of the pancreas as previously described (47) . Briefly, the pancreatic duct was ligated distally and injected with an ice-chilled solution of 630 units/ml collagenase (Type V collagenase; SigmaAldrich) and 5.5 mM glucose in Hank's balanced salt solution (HBSS). The pancreas was removed and incubated for 9 min at 37°C. The suspension was repeatedly passed through a 14-gauge needle. After several centrifugations and resuspensions in icecold HBSS, the dispersed pancreas was filtrated through a 500-m screen. The filtrate was pelleted and resuspended in Histopaque 1077 (Sigma-Aldrich). After centrifugation, islets were recovered from the interface and washed twice in HBSS. Individual islets were hand-picked and cultured in RPMI medium 1640 supplemented with 1% penicillin/streptomycin and 5% FBS at a concentration of 200 islets per milliliter in the presence or absence of IL-1␤ (50 units/ml; R&D Systems) and IFN-␥ (1,000 units/ml; R&D Systems) for the indicated periods. Cell media were assayed for nitrite production. Cell viability was quantified by using the WST assay according to the manufacturer's protocol (Roche).
STZ-Induced Diabetes. For the MLDS model, Ucp2-WT and Ucp2-KO male mice ages 11-13 weeks were injected i.p. for 5 consecutive days with either STZ (Sigma-Aldrich-) dissolved in citrate buffer (pH 4.5) at a concentration of 40 mg/kg or citrate buffer alone. The first day of injection was considered as day 1. For the single high-dose model, STZ was injected i.p. at a concentration of 250 mg/kg (19) . Blood glucose concentrations were measured two or three times a week by using an AccuCheck Active glucometer (Roche). Hyperglycemia was defined as a nonfasting blood glucose level of Ͼ200 mg/dl in two consecutive measurements (13) .
Peritoneal Macrophages. MLDS-or buffer-injected mice were killed on day 10. PBS was injected into the peritoneal cavity. The medium was aspirated out, peritoneal cells were counted, and 2 ϫ 10 5 cells were plated per well. Macrophages were purified by differential adherence over 1 h. Cells were washed with PBS and cultured in RPMI medium 1640 containing 2% FBS and 1% penicillin/streptomycin. NO Production. NO was measured as nitrite in medium. Samples were incubated with an equal volume of Griess reagent (SigmaAldrich) according to the manufacturer's instructions, and absorbance at 550 nm was measured. The nitrite concentration was obtained by comparison to a standard curve.
Cytokine Concentration Measurements. IL-1␤, IL-6, and MCP-1 concentrations were measured by using specific ELISA (R&D Systems) according to the manufacturer's instructions.
Insulitis and Immunohistochemistry. Mice were killed on days 10 and 19. Pancreata were removed and frozen in Tissue-Tek OCT, and 7-m sections were stained with H&E to determine the degree of insulitis. The degree of immune cell infiltration was set by using the following scores: 0, no infiltration; 1, minor infiltration; 2, clear infiltration. Results are presented as the percentage of islets per mouse in each category. At least 40 islets were counted per mouse blindly by two observers.
Immunohistochemistry was performed by using rat anti-mouse CD11b (BD Pharmingen), rabbit anti-mouse nitrotyrosine (Upstate), and the correspondent anti-Ig HRP detection kits (BD Pharmingen) according to the manufacturers' instructions. Slides were counterstained with hematoxylin (Sigma-Aldrich) and mounted under coverslips with Eukitt (Sigma-Aldrich). Statistical Analysis. The occurrence of diabetes was plotted by using the Kaplan-Meier method. Statistical comparison was performed by using the log-rank test. Significance of the differences in insulitis degree, glycemia, and immune parameters was determined by the Mann-Whitney test.
